Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review

Secord, AA; O'Malley, DM; Sood, AK; Westin, SN; Liu, JF

Secord, AA (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol,Duke Canc Inst, 20 Duke Med Circle, Durham, NC 27710 USA.

GYNECOLOGIC ONCOLOGY, 2021; 162 (2): 482

Abstract

Inhibitors of poly(ADP-ribose) polymerase (PARP) and angiogenesis have demonstrated single-agent activity in women with advanced ovarian cancer. Recen......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索